Wujin Sun

Wujin Sun serves as Assistant Professor in the Department of Biological Systems Engineering at Virginia Tech, leading interdisciplinary research at the convergence of cell engineering and biomaterials science. His work develops innovative therapeutic platforms for precision medicine applications across biomedical domains.

Education:

• Ph.D. in Biomedical Engineering (Joint), The University of North Carolina at Chapel Hill & North Carolina State University, 2017
• M.S. in Biochemical Engineering, Nanjing Tech University, China, 2013
• B.S. in Bioengineering, Nanjing Tech University, China, 2010

Dr. Sun's research program focuses on engineering cellular systems through synthetic biology tools while developing advanced drug delivery platforms including nano-formulations, wearable microneedle patches, and injectable depots. His tissue engineering work creates models for transplantation, disease simulation, and personalized therapeutic efficacy prediction, with strong emphasis on cancer immunotherapy and regenerative medicine applications. The integration of these approaches drives his vision for next-generation precision medicine solutions.

Analysis of recent publications reveals dominant themes in microneedle-based transdermal delivery systems, biomaterial-mediated immune modulation (particularly macrophage polarization and CAR-T cell engineering), and organ-on-chip disease models. His work spans cancer therapeutics, wound healing, and diabetes management with increasing emphasis on in vivo gene editing and smart responsive materials.

Scientific recognition:

• Terasaki Fellow

Dr. Sun mentors graduate students within Virginia Tech's Biological Systems Engineering program, securing research funding for his lab's development of minimally invasive devices and biomaterial platforms. His collaborations span bioengineering, oncology, and materials science disciplines to translate laboratory innovations toward clinical impact.

The Sun Lab operates from 301B Hahn Hall, utilizing specialized facilities for biomaterial synthesis, cell culture, and microdevice fabrication. The lab maintains active partnerships with the Terasaki Institute and UCLA, focusing on translating engineered cell-biomaterial systems into therapeutic applications for cancer and regenerative medicine.